64 results
Page 2 of 4
8-K
EX-99.1
k2zd321
14 Nov 22
ReShape Lifesciences Announces $750,000 Registered Direct Offering
6:19am
8-K
EX-4.1
rnbzi x7pf5
14 Nov 22
ReShape Lifesciences Announces $750,000 Registered Direct Offering
6:19am
424B5
qwbub c3j
9 Nov 22
Prospectus supplement for primary offering
11:56am
8-K
EX-4.1
djii8b3x8k z38shpv
23 Jun 22
Entry into a Material Definitive Agreement
4:38pm
8-K
EX-4.1
qelhp9ncuubaj
19 Jul 21
Entry into a Material Definitive Agreement
8:01am
8-K
EX-4.1
6v133q8c6
2 Jul 21
Entry into a Material Definitive Agreement
4:05pm
8-K
xjasm7t yv
15 Jun 21
Completion of Acquisition or Disposition of Assets
5:11pm
8-K
EX-3.3
wg6k4m7lvkoux
15 Jun 21
Completion of Acquisition or Disposition of Assets
5:11pm
424B3
hw4 g2ck41t7
13 Apr 21
Prospectus supplement
4:22pm
S-4/A
xvlrv bn3k21i2f
9 Apr 21
Registration of securities issued in business combination transactions (amended)
5:20pm
S-4
EX-10.34
4t3i xdezaqno
30 Mar 21
Registration of securities issued in business combination transactions
12:00am
S-4
EX-10.39
mhgcojuk7vy
30 Mar 21
Registration of securities issued in business combination transactions
12:00am
S-4
jzl5uoye
30 Mar 21
Registration of securities issued in business combination transactions
12:00am
S-4
EX-10.38
osiwa1cwkoy
30 Mar 21
Registration of securities issued in business combination transactions
12:00am
425
EX-10.1
06ot8
20 Jan 21
Business combination disclosure
8:45am